Hwang, W., Dearden, C., Loh, Y., Linn, Y., Tien, S., Teoh, G., . . . S'PORE, D. G. M. S. (2016). Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemia.
Chicago Style CitationHwang, W.Y.K., et al. Outpatient-based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients With Relapsed/refractory Chronic Lymphocytic Leukemia. 2016.
MLA引文Hwang, W.Y.K., et al. Outpatient-based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients With Relapsed/refractory Chronic Lymphocytic Leukemia. 2016.
警告：這些引文格式不一定是100％准確.